Pain in end-stage renal disease: A frequent and neglected clinical problem

Clinical Nephrology

Volumn 79, Issue SUPPL. 13, 2013, Pages

  Santoro, Domenico ^a   Satta, Ersilia ^a   Messina, Salvatore ^a   Costantino, Giuseppe ^a   Savica, Vincenzo ^a   Bellinghieri, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Electrotherapy; ESRD; Pain; Renal bone disease; Uremic neuropathy

Indexed keywords

CODEINE; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; GABAPENTIN; HYDROMORPHONE; MORPHINE; OPIATE; PARACETAMOL; PARATHYROID HORMONE;

AMYLOIDOSIS; ANXIETY DISORDER; ARTICLE; BREATHING EXERCISE; CALCEMIC UREMIC ARTERIOLOPATHY; CALCINOSIS; CARPAL TUNNEL SYNDROME; CHRONIC PAIN; COGNITIVE THERAPY; CONSTIPATION; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRY SKIN; ELECTROSTIMULATION THERAPY; FEEDBACK SYSTEM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH TONE EXTERNAL MUSCLE STIMULATION; HUMAN; HYPERTENSION; HYPNOSIS; IMPOTENCE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MEDITATION; NAUSEA; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTION; NOCICEPTIVE PAIN; OSTEITIS FIBROSA; OSTEOARTHRITIS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PAIN ASSESSMENT; PATIENT COUNSELING; PERCUTANEOUS NERVE STIMULATION; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHARMACOKINETICS; PRURITUS; QUALITY OF LIFE; SEDATION; SOCIAL BEHAVIOR; SOMNOLENCE; SPINAL CORD STIMULATION; STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; UREMIA; UREMIC NEPHROPATHY; VERTIGO; VOMITING; YOGA; CHRONIC KIDNEY FAILURE; COMORBIDITY; METHODOLOGY; MORTALITY; NEURALGIA; REVIEW;

COMORBIDITY; ELECTRIC STIMULATION THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84874399990     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNX77S104     Document Type: Article

References (64)

1. Merskey H, Bogduk N. Classification of Chronic Pain. Seattle, WA: International Association for the Study of Pain Press; 1994, p. 210.
2. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003; 42: 1239-1247. PubMed
3. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007; 14: 82-99. PubMed
4. Golan E, Haggiag I, Os P, Bernheim J. Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients. Clin J Am Soc Nephrol. 2009; 4: 1374-1380. Published online July 2, 2009. PubMed
5. Barakzoy AS, Moss AH. Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol. 2006; 17: 3198-3203. PubMed
6. Binik YM, Baker AG, Kalogeropoulos D, Devins GM, Guttmann RD, Hollomby DJ, Barré PE, Hutchison T, Prud'Homme M, McMullen L. Pain, control over treatment, and compliance in dialysis and transplant patients. Kidney Int. 1982; 21: 840-848. PubMed
7. Milinkovic M, Zidverc-Trajkovic J, Sternic N, Trbojevic-Stankovic J, Maric I, Milic M, Andric B, Nikic P, Jovanovic P, Rosic P, Stojimirovic B. Hemodialysis headache. Clin Nephrol. 2009; 71: 158-163. PubMed
8. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int. 2004; 65: 2419-2425. PubMed
9. Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007; 2: 960-967. PubMed
10. Schneider J. In: Living With Chronic Pain: The complete Health Guide to the Causes and Treatment of Chronic Pain. Hatherleigh Press 2004.
11. Antoniazzi AL, Bigal ME, Bordini CA, Speciali JG. Headache associated with dialysis: the International Headache Society criteria revisited. Cephalalgia. 2003; 23: 146-149. PubMed
12. Ritz E, Schömig M, Bommer J. Osteodystrophy in the millennium. Kidney Int Suppl. 1999; 73: S94-S98. PubMed
13. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002; 15: 172-186. PubMed
14. Reslerova M, Moe SM. Vascular calcification in dialysis patients: pathogenesis and consequences. Am J Kidney Dis. 2003; 41 (Suppl 1): S96-S99. PubMed
15. Ross EA. Evolution of treatment strategies for calciphylaxis. Am J Nephrol. 2011; 34: 460-467. Published online October 6, 2011 PubMed
16. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006; 21: 1104-1108. Published online January 23, 2006. PubMed
17. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol. 2003; 15: 785-790. PubMed
18. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004; 107: 1-16. PubMed
19. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc. 1971; 46: 400-431. PubMed
20. Nielsen VK. The peripheral nerve function in chronic renal failure. II. Intercorrelation of clinical symptoms and signs and clinical grading of neuropathy. Acta Med Scand. 1971; 190: 113-117. PubMed
21. Nielsen VK. The peripheral nerve function in chronic renal failure. I. Clinical symptoms and signs. Acta Med Scand. 1971; 190: 105-111. PubMed
22. Vita G, Messina C, Savica V, Bellinghieri G. Uraemic autonomic neuropathy. J Auton Nerv Syst. 1990; 30 (Suppl): S179-S184. PubMed
23. Vita G, Savica V, Milone S, Trusso A, Bellinghieri G, Messina C. Uremic autonomic neuropathy: recovery following bicarbonate hemodialysis. Clin Nephrol. 1996; 45: 56-60. PubMed
24. Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH. Two year's experience with periodic hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs. 1962; 8: 266-280. PubMed
25. Brunner H, Mann H. What remains of the "middle molecule" hypothesis today? Contrib Nephrol. 1985; 44: 14-39. PubMed
26. Massry SG. Parathyroid hormone: a uremic toxin. Adv Exp Med Biol. 1987; 223: 1-17. PubMed
27. Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve. 2007; 35: 273-290. PubMed
28. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain. 2004; 127: 294-303. PubMed
29. Bolton CF, Baltzan MA, Baltzan RB. Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study. N Engl J Med. 1971; 284: 1170-1175. PubMed
30. Krishnan AV, Pussell BA, Kiernan MC. Neuromuscular disease in the dialysis patient: an update for the nephrologist. Semin Dial. 2009; 22: 267-278. Published online April 5, 2009 PubMed
31. Mitz M, Di Benedetto M, Klingbeil GE, Melvin JL, Piering W. Neuropathy in end-stage renal disease secondary to primary renal disease and diabetes. Arch Phys Med Rehabil. 1984; 65: 235-238. PubMed
32. Noordzij M, Boeschoten EW, Bos WJ, Dekker FW, Bossuyt PM, Krediet RT, Korevaar JC; for the NECOSAD Study Group. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant. 2007; 22: 2944-2949. Published online June 27, 2007. PubMed
33. Gribkoff VK. The role of voltage-gated calcium channels in pain and nociception. Semin Cell Dev Biol. 2006; 17: 555-564. Published online September 23, 2006. PubMed
34. Mascarenhas R, Mobarhan S. Hypovitaminosis D-induced pain. Nutr Rev. 2004; 62: 354-359. PubMed
35. Spertini F, Wauters JP, Poulenas I. Carpal tunnel syndrome: a frequent, invalidating, long-term complication of chronic hemodialysis. Clin Nephrol. 1984; 21: 98-101. PubMed
36. Nardin R, Chapman KM, Raynor EM. Prevalence of ulnar neuropathy in patients receiving hemodialysis. Arch Neurol. 2005; 62: 271-275. PubMed
37. Bolton CF, Driedger AA, Lindsay RM. Ischaemic neuropathy in uraemic patients caused by bovine arteriovenous shunt. J Neurol Neurosurg Psychiatry. 1979; 42: 810-814. PubMed
38. Bajwa ZH, Sial KA, Malik AB, Steinman TI. Pain patterns in patients with polycystic kidney disease. Kidney Int. 2004; 66: 1561-1569. PubMed
39. Hogan MC, Norby SM. Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010; 17: e1-e16. PubMed
40. Bajwa ZH, Gupta S, Warfield CA, Steinman TI. Pain management in polycystic kidney disease. Kidney Int. 2001; 60: 1631-1644. PubMed
41. Ishikawa I. Uremic acquired renal cystic disease. Natural history and complications. Nephron. 1991; 58: 257-267. PubMed
42. Kimmel PL, Emont SL, Newmann JM, Danko H, Moss AH. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003; 42: 713-721. PubMed
43. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Sympt Manage. 2005; 5: 465-73.
44. Noble H, Meyer PJ, Bridge DJ, Johnson DB, Kelly DD. Exploring symptoms in patients managed without dialysis: a qualitative research study. J Ren Care. 2010; 36: 9-15. PubMed
45. Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med. 2011; 12: 996-1004.10.1111/j.1526-4637.2011.01187.x PubMed
46. Davison SN. Chronic pain in end-stage renal disease. Adv Chronic Kidney Dis. 2005; 12: 326-334. PubMed
47. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000; 89: 7-18. PubMed
48. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, Gitelman DR. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004; 24: 10410-10415. PubMed
49. Bruehl S, Chung OY, Jirjis JN, Biridepalli S. Prevalence of clinical hypertension in patients with chronic pain compared to nonpain general medical patients. Clin J Pain. 2005; 21: 147-153. PubMed
50. Osborne R, Joel S, Grebenik K, Trew D, Slevin M. The pharmacokinetics of morphine and morphineglucuronides in kidney failure. Clin Pharmacol Ther. 1993; 54: 158-167. PubMed
51. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis. 2003; 42: 217-228. PubMed
52. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004; 28: 497-504. PubMed
53. Salisbury EM, Game DS, Al-Shakarchi I, Chan M, Fishman L, Tookman L, Brown EA. Changing practice to improve pain control for renal patients. Postgrad Med J. 2009; 85: 30-33. PubMed
54. Pham P-CT, Toscano E, Pham P-MT, et al. Pain management in patients with chronic kidney disease. NDT Plus. 2009; 2: 111-118. doi:10.1093/ ndtplus/sfp001
55. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006; 174: 1589-1594. PubMed
56. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005; 118: 289-305. PubMed
57. Lang EV, Benotsch EG, Fick LJ, Lutgendorf S, Berbaum ML, Berbaum KS, Logan H, Spiegel D. Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet. 2000; 355: 1486-1490. PubMed
58. Kuphal KE, Fibuch EE, Taylor BK. Extended swimming exercise reduces inflammatory and peripheral neuropathic pain in rodents. J Pain. 2007; 8: 989-997. PubMed
59. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006; 20: 216-223. PubMed
60. Yurtkuran M, Alp A, Yurtkuran M, Dilek K. A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study. Complement Ther Med. 2007; 15: 164-171. PubMed
61. DeSantana JM, Walsh DM, Vance C, Rakel BA, Sluka KA. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep. 2008; 10: 492-499. PubMed
62. Reichstein L, Labrenz S, Ziegler D, Martin S. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia. 2005; 48: 824-828. PubMed
63. Humpert PM, Morcos M, Oikonomou D, Schaefer K, Hamann A, Bierhaus A, Schilling T, Nawroth PP. External electric muscle stimulation improves burning sensations and sleeping disturbances in patients with type 2 diabetes and symptomatic neuropathy. Pain Med. 2009; 10: 413-419. PubMed
64. Klassen A, Di Iorio B, Guastaferro P, Bahner U, Heidland A, De Santo N. High-tone external muscle stimulation in end-stage renal disease: effects on symptomatic diabetic and uremic peripheral neuropathy. J Ren Nutr. 2008; 18: 46-51. PubMed